Comprehensive testing for every type of cancer with advanced genomic analysis
Results in 24 Hours
Get your results the next day, no weeks of waiting, no anxiety limbo
97.7% Accuracy
Industry-leading precision with validated clinical-grade testing protocols
For Providers
OncoSure’s Advanced Cancer Screening Technology.
Detecting cancer can be challenging due to limited existing screening tests, long turnaround times, high costs, and invasive procedures. OncoSure's innovative technology allows for early detection, even at stage -1, and provides crucial information for guiding further imaging tests with our detailed Oncosome count.
OncoSure's advanced cancer screening technology utilizes rapid in situ hybridization and DNA fluorescent probes, offering comprehensive cancer screening with high accuracy. Our approach includes a rapid SITU Hybridization Platform, DNA Fluorescent Probes for ploidy detection, and inexpensive density gradient and low sequential centrifugation, which enable comprehensive screening for aneuploidy of all chromosomes.
Hear directly from our customers about their experience with OncoSure
About OncoSure
Our Mission is to Revolutionize Cancer Detection.
The best way to fight cancer is to catch it early. Regular screenings dramatically improve your chances of a better outcome. Effective screenings can:
Detect cancer early, giving you a better chance at successful treatment.
Lower your risk of dying from cancer through regular monitoring.
Provide fast results, so you can take action sooner.
Cancer develops due to both genetic and metabolic changes in the body. OncoSure’s test looks at key genomic signals—offering a smarter, more comprehensive way to screen for cancer before symptoms appear.
We’re committed to staying at the forefront of early cancer detection—leveraging both current science and emerging research to keep improving patient outcomes.
Our team of board-certified physicians, molecular scientists, and laboratory professionals brings decades of experience in molecular diagnostics, pathology, and precision medicine to deliver the highest quality testing services.
Oversees all clinical and operational aspects of the laboratory, ensuring compliance with regulatory standards and maintaining the highest levels of diagnostic accuracy.
Advanced Certifications
Jahmar Hudson
Chief Scientific Officer & Technical Supervisor
Molecular Diagnostics & Pharmacogenomics
Education:
University of Cincinnati (MS Pharmacogenomics)
Nova Southeastern University (PhD in progress)
Areas of Expertise:
Molecular Diagnostics
Pharmacogenomics
Quality Assurance
Provides scientific leadership and technical oversight of molecular diagnostics, focusing on assay development, validation, and regulatory compliance.
CLIA Supervisor
Stephanie Altidort
General Supervisor, Molecular Pathology
Molecular Diagnostics & Genomics
Education:
Florida Atlantic University (BS Neuroscience)
Areas of Expertise:
High-Complexity Testing
Quality Control
Staff Management
Supervises high-complexity molecular testing procedures and ensures compliance with CLIA regulatory standards and laboratory accreditation requirements.
Clinical Specialist
Stephanie Lucce
Molecular Technologist
Biotechnology & Molecular Pathology
Education:
Miami Dade College (BS Biotechnology)
Areas of Expertise:
PCR Techniques
Nucleic Acid Analysis
Genetic Testing
Executes high-complexity molecular assays including nucleic acid extraction, PCR amplification, and genetic analysis for infectious diseases and genetic conditions.
20+ Years Experience
William Wysock
Molecular Scientist
Validation & Process Development
Education:
Catholic University of America (MS Biology)
Loyola University (BA Writing)
Areas of Expertise:
Method Validation
NGS Technologies
Six Sigma Quality
Oversees validation processes and complex technical inquiries, with extensive experience in molecular methodologies and regulatory compliance.
Don't Wait for Symptoms! Ask Your Doctor About OncoSure.
Your doctor can help you decide when to get screened, but OncoSure gives you a head start. Here are four common cancers where early detection makes all the difference.
Lung Cancer
If you’re a smoker over 50, OncoSure may detect early signs, even before changes appear on scans.
Cervical Cancer
Women 21 and older should get regular cervical screenings. OncoSure offers an additional way to monitor your health.
Breast Cancer
Mammograms are recommended starting at age 40. OncoSure offers added insight between screenings or when symptoms are unclear.
Colon Cancer
Colonoscopies are vital starting at age 45. OncoSure may help detect early changes before you're eligible, or in between routine screenings.
Beyond oncology, we offer comprehensive genetic testing services to optimize your healthcare journey. From personalized medication selection to disease risk assessment, unlock the power of your DNA for better health decisions.
Pharmacogenomics (PGx)
Optimize medication selection and dosing based on your genetic profile for safer, more effective treatment.
From pharmacogenomics to wellness panels, our genetic testing services complement our oncology expertise to provide a complete picture of your health. Discover how your DNA can guide better treatment decisions and preventive care.
This test was developed, and its performance characteristics were determined by OncoSure Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. The test was performed in a CLIA-certified laboratory and is intended for clinical purposes. OncoSure Laboratories is also COLA-accredited, having received a perfect score on its most recent inspection.
